Proliferation assessment in breast carcinomas using digital image analysis based on virtual Ki67/cytokeratin double staining

Breast Cancer Research and Treatment

Volumn 158, Issue 1, 2016, Pages 11-19

  Røge, Rasmus ^a,b   Riber Hansen, Rikke ^c   Nielsen, Søren ^a   Vyberg, Mogens ^a,b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Breast carcinoma; Digital image analysis; Immunohistochemistry; Ki67; Standardization; Virtual double staining

Indexed keywords

CYTOKERATIN; KI 67 ANTIGEN; KERATIN;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER CLASSIFICATION; COMPUTER PROGRAM; CONTROLLED STUDY; DIGITAL IMAGING; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LUMINAL A BREAST CANCER; LUMINAL B BREAST CANCER; MAJOR CLINICAL STUDY; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; STEREOMETRY; TISSUE MICROARRAY; TUMOR GROWTH; VIRTUAL DOUBLE STAINING; ALGORITHM; BREAST TUMOR; CELL COUNT; CELL PROLIFERATION; CLASSIFICATION; COMPARATIVE STUDY; FEMALE; IMAGE PROCESSING; METABOLISM; MITOSIS INDEX; MOLECULAR IMAGING; PROCEDURES; REPRODUCIBILITY;

ALGORITHMS; BREAST NEOPLASMS; CELL COUNT; CELL PROLIFERATION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KERATINS; KI-67 ANTIGEN; MITOTIC INDEX; MOLECULAR IMAGING; REPRODUCIBILITY OF RESULTS; STAINING AND LABELING;

EID: 84973665437     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-016-3852-6     Document Type: Article

References (19)

1. Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol 182:311–322. doi:10.1002/(SICI)1097-4652(200003)182:3<311:AID-JCP1>3.0.CO;2-9
2. de Azambuja E, Cardoso F, de Castro G et al (2007) Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br J Cancer 96:1504–1513. doi:10.1038/sj.bjc.6603756
3. Bosman FT, Carneiro F, Hruban R, Theise N (2010) Classification of tumours of the digestive system. WHO, Lyon
4. Bettini R, Boninsegna L, Mantovani W et al (2008) Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours. Ann Oncol 19:903–908. doi:10.1093/annonc/mdm552
5. Goldhirsch A, Wood WC, Coates AS (2011) Strategies for subtypes–dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 22:1736–1747. doi:10.1093/annonc/mdr304
6. Goldhirsch A, Winer EP, Coates AS (2013) Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol 24:2206–2223. doi:10.1093/annonc/mdt303
7. Shui R, Yu B, Bi R et al (2015) An interobserver reproducibility analysis of Ki67 visual assessment in breast cancer. PLoS ONE 10:e0125131. doi:10.1371/journal.pone.0125131
8. Mikami Y, Ueno T, Yoshimura K et al (2013) Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 ring study. Cancer Sci 104:1539–1543. doi:10.1111/cas.12245
9. Polley M-YC, Leung SCY, McShane LM et al (2013) An international Ki67 reproducibility study. J Natl Cancer Inst 105:1897–1906. doi:10.1093/jnci/djt306
10. Polley M-YC, Leung SCY, Gao D et al (2015) An international study to increase concordance in Ki67 scoring. Mod Pathol 28:778–786. doi:10.1038/modpathol.2015.38
11. Laurinavicius A, Plancoulaine B, Laurinaviciene A et al (2014) A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue. Breast Cancer Res 16:R35. doi:10.1186/bcr3639
12. Tuominen VJ, Ruotoistenmäki S, Viitanen A et al (2010) Immunoratio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Breast Cancer Res 12:R56. doi:10.1186/bcr2615
13. Fasanella S, Leonardi E, Cantaloni C et al (2011) Proliferative activity in human breast cancer: ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies. Diagn Pathol 6(Suppl 1):S7. doi:10.1186/1746-1596-6-S1-S7
14. 0 breast cancer. Pol J Pathol 64:1–8
15. Nielsen PS, Riber-Hansen R, Jensen TO et al (2013) Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma. Mod Pathol 26:404–413. doi:10.1038/modpathol.2012.188
16. Gundersen HJ, Bendtsen TF, Korbo L et al (1988) Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96:379–394
17. Narbe U, Bendahl P-O, Grabau D et al (2014) Invasive lobular carcinoma of the breast: long-term prognostic value of Ki67 and histological grade, alone and in combination with estrogen receptor. Springerplus 3:70. doi:10.1186/2193-1801-3-70
18. Alvarenga CA, Paravidino PI, Alvarenga M et al (2012) Reappraisal of immunohistochemical profiling of special histological types of breast carcinomas: a study of 121 cases of eight different subtypes. J Clin Pathol 65:1066–1071. doi:10.1136/jclinpath-2012-200885
19. Sterio DC (1984) The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc 134:127–136